Anxiety and COPD Evaluation

NACompletedINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

January 31, 2016

Primary Completion Date

March 1, 2019

Study Completion Date

March 1, 2019

Conditions
Chronic Obstructive Pulmonary Disease
Interventions
BEHAVIORAL

Anxiety Inventory for Respiratory Disease (AIR)

An initial version of the AIR was developed through a mixed-methods approach to item development, incorporating both emic and etic perspectives. This included an extensive review of extant anxiety scales (etic perspectives) and in-depth qualitative interviews with patients with COPD and self-reported anxiety (emic perspectives). AIR has ten items on a scale from 0 to 3. It provides a score of 0-30. High score indicates elevated level of clinically relevant anxiety symptoms.

BEHAVIORAL

Hospital Anxiety and Depression Scale (HADS)

The Hospital Anxiety and Depression Scale (HADS), a self-assessment scale, was developed to detect states of depression, anxiety and emotional distress amongst patients who were being treated for a variety of clinical problems.

Trial Locations (1)

10016

New York University School of Medicine, New York

All Listed Sponsors
lead

NYU Langone Health

OTHER

NCT02740465 - Anxiety and COPD Evaluation | Biotech Hunter | Biotech Hunter